T. Rowe Price Exchange-Traded Funds, Inc. (TMED)
Management Company · XNAS · Series S000092023 · View on SEC EDGAR ↗
$36.31
As of Aug. 21, 2026
▲ +0.41 (+1.13%)
1-day change
$24.99 – $36.72
52-week range
Holdings data is not available for this fund yet.
On this page
- Price chart The fund's market price over time, with technical overlays.
- Performance Total return, volatility, drawdown and other risk metrics.
- Fund flows Money flowing in and out of the fund each month, from N-PORT filings.
- Holdings Every position the fund currently holds, with weights.
- Institutional owners 13F institutions that report holding this ETF.
- Similar funds Other funds with overlapping holdings or comparable size.
TMED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
Performance as of Aug. 20, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▲ +20.90% | — |
| 3M | ▲ +20.90% | — |
| 6M | ▲ +21.09% | — |
| YTD | ▲ +20.79% | — |
| 1Y | ▲ +42.73% | — |
| 3Y | — | — |
| 5Y | — | — |
| Max since June 12, 2025 | ▲ +42.87% | — |
- Volatility 1Y
- 28.37%
- Volatility 3Y
- —
- Max drawdown 3Y
- —
- Beta 3Y
- —
- Sharpe 1Y*
- 2.24
Total return is shown once dividend history for this fund has been collected — price return alone would duplicate it misleadingly. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
- Last month (Mar 2026)
- +$1.4M
- Quarter ending Mar 2026
- +$4.4M
- Trailing 12 months
- +$18.2M
Apr 2025 – Mar 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 109 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| ALKERMES PLC | G01767105 | $108K | 0.53 | 3,048 | EC | IE |
| RAPPORT THERAPEUTICS INC | 75383L102 | $106K | 0.52 | 3,392 | EC | US |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | $104K | 0.51 | 5,110 | EC | US |
| AVALO THERAPEUTICS INC | 05338F306 | $103K | 0.51 | 6,914 | EC | US |
| KODIAK SCIENCES INC | 50015M109 | $103K | 0.51 | 2,705 | EC | US |
| ERASCA INC | 29479A108 | $103K | 0.51 | 6,348 | EC | US |
| NATERA INC | 632307104 | $101K | 0.50 | 504 | EC | US |
| DENALI THERAPEUTICS INC | 24823R105 | $98K | 0.48 | 5,116 | EC | US |
| NOVOCURE LTD | G6674U108 | $94K | 0.46 | 8,598 | EC | JE |
| GRS - SECURITY LENDING COLLATERAL | 76105YYY9 | $94K | 0.46 | 93,610 | STIV | US |
| STEVANATO GROUP SPA | T9224W109 | $89K | 0.44 | 6,509 | EC | IT |
| GUARDANT HEALTH INC | 40131M109 | $86K | 0.42 | 929 | EC | US |
| ARCUS BIOSCIENCES INC | 03969F109 | $83K | 0.41 | 3,833 | EC | US |
| STOKE THERAPEUTICS INC | 86150R107 | $80K | 0.40 | 2,468 | EC | US |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | $79K | 0.39 | 5,711 | EC | US |
| CENTESSA PHARMACEUTICALS-ADR | 152309100 | $79K | 0.39 | 1,990 | EC | GB |
| EDWARDS LIFESCIENCES CORP | 28176E108 | $78K | 0.38 | 971 | EC | US |
| IMMUNOCORE HOLDINGS PLC-ADR | 45258D105 | $74K | 0.37 | 2,468 | EC | GB |
| GRAIL INC | 384747101 | $73K | 0.36 | 1,404 | EC | US |
| DIANTHUS THERAPEUTICS INC | 252828108 | $71K | 0.35 | 848 | EC | US |
| ICON PLC | G4705A100 | $68K | 0.33 | 612 | EC | IE |
| PRIME MEDICINE INC | 74168J101 | $64K | 0.32 | 18,451 | EC | US |
| CRINETICS PHARMACEUTICALS IN | 22663K107 | $64K | 0.32 | 1,758 | EC | US |
| IONIS PHARMACEUTICALS INC | 462222100 | $64K | 0.32 | 850 | EC | US |
| EIKON THERAPEUTICS INC | 282564103 | $62K | 0.30 | 5,840 | EC | US |
| INTUITIVE SURGICAL INC | 46120E602 | $62K | 0.30 | 134 | EC | US |
| CARIS LIFE SCIENCES INC | 142152107 | $60K | 0.30 | 3,377 | EC | US |
| TRAVERE THERAPEUTICS INC | 89422G107 | $59K | 0.29 | 1,982 | EC | US |
| GENEDX HOLDINGS CORP | 81663L200 | $57K | 0.28 | 891 | EC | US |
| DISC MEDICINE INC | 254604101 | $54K | 0.27 | 841 | EC | US |
| RELAY THERAPEUTICS INC | 75943R102 | $52K | 0.26 | 5,205 | EC | US |
| ANNEXON INC | 03589W102 | $52K | 0.25 | 9,315 | EC | US |
| YPSOMED HOLDING AG-REG | CH02SWN84 | $50K | 0.25 | 142 | EC | CH |
| AKTIS ONCOLOGY INC | 01021M104 | $49K | 0.24 | 2,721 | EC | US |
| OSCAR HEALTH INC - CLASS A | 687793109 | $46K | 0.23 | 3,999 | EC | US |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $44K | 0.22 | 1,135 | EC | US |
| CHARLES RIVER LABORATORIES | 159864107 | $43K | 0.21 | 252 | EC | US |
| BRUKER CORP | 116794108 | $43K | 0.21 | 1,196 | EC | US |
| BIOHAVEN LTD | G1110E107 | $39K | 0.19 | 4,623 | EC | VG |
| PROCEPT BIOROBOTICS CORP | 74276L105 | $36K | 0.18 | 1,450 | EC | US |
| CRISPR THERAPEUTICS AG | H17182108 | $34K | 0.17 | 709 | EC | CH |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | $33K | 0.16 | 15,543 | EC | US |
| BIO-TECHNE CORP | 09073M104 | $31K | 0.15 | 593 | EC | US |
| OLEMA PHARMACEUTICALS INC | 68062P106 | $30K | 0.15 | 1,997 | EC | US |
| STATE STREET INS US GO MM FD-IS | 857492706 | $27K | 0.13 | 27,008 | STIV | US |
| SOLENO THERAPEUTICS INC | 834203309 | $26K | 0.13 | 780 | EC | US |
| PERSONALIS INC | 71535D106 | $25K | 0.13 | 3,980 | EC | US |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | $25K | 0.12 | 4,484 | EC | US |
| JANUX THERAPEUTICS INC | 47103J105 | $20K | 0.10 | 1,455 | EC | US |
| TANGO THERAPEUTICS INC | 87583X109 | $20K | 0.10 | 933 | EC | US |
Page 2
of 3
Institutional owners (13F) 4 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| COMMONWEALTH EQUITY SERVICES, LLC | $329,060 | 38.98% | 9,635 | Shares | June 30, 2026 |
| Essex Financial Services, Inc. | $310,790 | 36.82% | 9,100 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $203,482 | 24.11% | 5,958 | Shares | June 30, 2026 |
| FLOW TRADERS U.S. LLC | $814 | 0.10% | 23,827 | Shares | June 30, 2026 |
Peer funds
More from this issuer
| Fund | AUM |
|---|---|
| TAGG T. Rowe Price Exchange-Traded F… | $1.9B |
| TOUS T. Rowe Price Exchange-Traded F… | $1.4B |
| TBUX T. Rowe Price Exchange-Traded F… | $1.1B |
| THYF T. Rowe Price Exchange-Traded F… | $815.6M |
| TFLR T. Rowe Price Exchange-Traded F… | $613.4M |
| TOTR T. Rowe Price Exchange-Traded F… | $561.8M |
| TAXE T. Rowe Price Exchange-Traded F… | $156.7M |
| TIER T. Rowe Price Exchange-Traded F… | $27.6M |
| THYM T. Rowe Price Exchange-Traded F… | $25.3M |
| TMNL T. Rowe Price Exchange-Traded F… | $22.6M |
Similar by size
| Fund | AUM |
|---|---|
| SCAP Series Portfolios Trust | $20.4M |
| MRCP PGIM Rock ETF Trust | $20.5M |
| WANT Direxion Shares ETF Trust | $20.5M |
| AVGB AMERICAN CENTURY ETF TRUST | $20.5M |
| JHAI Janus Detroit Street Trust | $20.5M |
| JULP PGIM Rock ETF Trust | $20.1M |
| GDOC Goldman Sachs ETF Trust | $20.1M |
| TPLS Thornburg ETF Trust | $20.1M |
| SETH ProShares Trust | $20.1M |
| SEPP PGIM Rock ETF Trust | $20.0M |